US Edition
News from SRI News
If you want to know if SRI News is credible or reliable, look no further. We rank SRI News as High factuality. Find out more about our methodology here.
Media Bias Ratings
Average Bias Rating:
Center
Center
byAd Fontes MediaCenter
byAll SidesDo you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top SRI News News
Meishan · MeishanMEISHAN, China, June 5, 2025 /PRNewswire/ -- Recently, Wanhua Chemical Battery Technology Co., Ltd. (hereinafter referred to as "Wanhua Chemical") and ElevenEs, a leading European manufacturer of lithium iron phosphate (LFP) batteries, successfully signed a Memorandum of Understanding (MOU) in Meishan, Sichuan. Mr. Wang Xiaoxing, General Manager of Wanhua Chemical Battery Technology Co., Ltd., and Mr. Nemanja Mikać, Founder and CEO of ElevenEs, …See the Story
Wanhua Chemical and ElevenEs signed a strategic agreement for battery materials: Collaborate to create a localized supply chain of battery cathode materials in Europe
66% Center coverage: 35 sources
Shanghai, China · ShanghaiSHANGHAI, June 5, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage biotechnology company developing in vivo genome editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for YOLT-101, an…See the Story
YolTech Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for YOLT-101, an In Vivo Base Editing Therapy to Treat Heterozygous Familial Hypercholesterolemia (HeFH)
64% Center coverage: 34 sources
Chengdu · ChengduCHENGDU, China, June 5, 2025 /PRNewswire/ -- On June 5, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced the placement of 5,918,000 H shares under its general mandate, representing approximately 2.54% of the enlarged share capital…See the Story
Kelun-Biotech Announces Approximately US$250 Million Placement
64% Center coverage: 34 sources
Markel Announces Collaboration with Insurate to Advance Middle-Market Workers Compensation Through AI and Innovative Safety Scoring
63% Center coverage: 19 sources
Sun Life U.S. congratulates Congressmen DeSaulnier and Scott on introduction of historic legislation to enhance coverage of mental health conditions in long-term disability insurance
75% Center coverage: 28 sources
QRL Emerges as the Post-Quantum Standard as BlackRock Warns of Quantum Threat to Bitcoin and Ethereum
70% Center coverage: 10 sources
Former NY Chief of Police Bill Herlihy Serves Community with New Role: iCRYO Franchise Owner
67% Center coverage: 21 sources
Republic of Peru Announces Exchange Consideration
76% Center coverage: 29 sources
MIRASOL GENERAL MANAGER MATT LAMBERT NAMED 2025 FACILITY MANAGER OF THE YEAR
68% Center coverage: 16 sources
Private Astronaut Mission Includes Research to Open Space to Astronauts With Diabetes and Enable Early Cancer Detection
86% Center coverage: 7 sources
Kling AI Celebrates First Anniversary; Achieves Annualized Revenue Run Rate Surpassing USD100 Million in 10th Month Since Launch
76% Center coverage: 29 sources
